GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » GF Value

COSM (Cosmos Health) GF Value : $0.37 (As of Jun. 22, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Cosmos Health GF Value?

As of today (2025-06-22), Cosmos Health's share price is $0.4317. Cosmos Health's GF Value is $0.37. Therefore, Cosmos Health's Price-to-GF-Value for today is 1.17. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Cosmos Health is Modestly Overvalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

  1. We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
  2. We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
  3. Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.


Cosmos Health  (NAS:COSM) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations All-in-One Screener Examples (1)
Possible Value Trap, Think TwicePredictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.


Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.


Cosmos Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.4317/0.37
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmos Health GF Value Related Terms

Thank you for viewing the detailed overview of Cosmos Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmos Health Business Description

Traded in Other Exchanges
Address
5 Agiou Georgiou Street, Thessaloniki, Thessaloniki, GRC, 55438
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Executives
Grigorios Siokas 10 percent owner 5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001
Georgios Terzis officer: Chief Financial Officer 2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121
Suhel Bhutawala director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Nikolaos Bardakis officer: Chief Operating Officer 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Manfred Ziegler director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Anastasios Aslidis director 11 CANTERBURY LANE, WATCHUNG NJ 07069
Pavlos Ignatiades officer: Chief Operating Officer KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236
Peter Goldstein director 151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324
John James Hoidas director 9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453
Dimitrios Goulielmos director, 10 percent owner, officer: CEO 141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604
Panagiotis Tolis director, officer: Secretary PERICLEOUS 50 STREET, ATHENS J3 15232
Panagiotis Drakopoulos director, 10 percent owner, officer: CEO 200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606
Vasileios Mavrogiannis director, 10 percent owner, officer: CFO TERTSETI 23 STREET, KESARIANI J3 16122

Cosmos Health Headlines

From GuruFocus